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Abstract 
Open aortic surgery evokes a systemic inflammatory response and is associated with high morbidity and mortality. 
Purinergic signaling has been shown to be crucial for maintaining vascular integrity and attenuating inflammation 
related to hypoxia. The involvement of purinergic signaling in cross clamping of major human arteries is unknown. 
Our aim was to compare systemic inflammatory responses and hypoxia-induced purinergic signaling in patients 
undergoing either open infra-renal abdominal aortic repair or infra-inguinal revascularization. Pre- and 24 h post-
operative blood samples were gathered from 6 patients undergoing aortic clamping and 6 similar patients under-
going common femoral artery cross-clamping. Using Biorad Multipex™ 21- and 27-panels 48 different cytokines, 
chemokines and growth factors were analyzed, in addition to circulating levels of ATP, ADP, CD39, CD73 and HIF-1α, 
and compared between the groups. Several inflammatory cytokines were elevated from baseline levels after aortic 
clamping, but not after femoral cross clamping. Most pronoun rises were seen in IL-6 (667 %, P = 0.016) and HGF 
(760 %, P = 0.016). HIF-1α values showed a steady increase after clamping of either artery unless the subject under-
went blood transfusion. Despite an adequate increase in HIF-1α CD39 and CD73 activity decreased significantly after 
aortic clamping (P = 0.047 and P = 0.016, respectively). Aortic clamping is associated with a clear and strong systemic 
inflammatory response and impaired repair mechanisms in terms of purinergic signaling. Patients undergoing open 
aorta repair could benefit from pre-operative medical therapy, which enhances CD73 expression.
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Background
Acute organ injury remains one of the leading causes of 
morbidity and mortality in surgical patients (Eltzschig 
2013). A highlight of such surgery is open aortic cross 
clamping and reconstruction, which is associated with a 
systemic inflammatory response syndrome (SIRS) (Bown 
et al. 2001; Vasdekis et al. 2008) and dysfunction of central 
organs, especially the lungs, kidneys and intestine (Brady 
et al. 2000; Papia et al. 2006; Moris et al. 2014). Thus, open 
aorta repair has been referred to as the ultimate stress test 
(Ali et al. 2008). Patients undergoing major vascular surgery 
are also often burdened by other significant cardiovascular 
illnesses. This is especially the case amongst patients with 
peripheral artery disease (PAD), for whom the prevalence 
of cardiovascular co-morbidities is significantly elevated 
(Gallino et al. 2014). It has been shown that patients under-
going surgery of the lower limb for PAD have even more 
peri/post-operative myocardial morbidity than do patients 
undergoing aorta repair due to abdominal aortic aneu-
rysm (AAA), but yet patients undergoing aortic surgery 
have a worse scenario (Krupski et al. 1992; Ali et al. 2008). 
This has lead to the conception that cross clamping of the 
infra-renal abdominal aorta leads to a markedly different 
hypoxia-induced pathophysiologic response than the cross-
clamping of the iliac or common femoral artery.
Extra cellular CD73 (ecto-5′-nucleotidase/NT5E) derived 
adenosine production is considered a key pathway in atten-
uating hypoxia-induced inflammation (Thompson et  al. 
2004; Eltzschig et al. 2012) and protective of several central 
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organs (Grenz et al. 2007; Eckle et al. 2007; Hart et al. 2011). 
The key driver of this response is hypoxia-induced factor-1 
alpha (HIF-1α). However, the current background litera-
ture of this pathway is mostly derived from animal studies, 
in which cross-clamping of central arteries has been widely 
used to provoke reperfusion injury and a systemic inflam-
matory response in order to study different organ failures 
(Grenz et al. 2007; Kiss et al. 2007; Hart et al. 2011).
Thus, in this study our objective was to study the sys-
temic inflammatory and growth factor response of aor-
tic cross clamping. In addition, to further understand 
hypoxia-induced repair mechanisms in relation to cross 
clamping of a major artery, components of purinergic 
signaling were analyzed. Pre- and post-operative levels of 
48 different cytokines, chemokines and growth-factors, 
in addition to ATP, ADP, CD39, CD73 and HIF-1α, were 
analyzed from blood samples of six PAD patients under-
going open repair of the infra-renal abdominal aorta and 
were compared to six similar risk factor matched PAD 
patients undergoing infra-inguinal vascular surgery and 
cross-clamping of the common femoral artery.
Results and discussion
Description of the study subjects
The study group baseline data is presented in Table  1. 
The groups were well matched and were mostly without 
any statistically significant differences. Patients under-
going open aorta repair tended to be a bit younger and 
had slightly less renal insufficiency and coronary artery 
disease (CAD), see Table 1A. The groups were also com-
parable based on major issues relating to procedural 
variables such clamping time and blood loss (Table 1B). 
The only significant difference was seen in the amount of 
transfusion of saline products received between the sam-
pling. Subjects undergoing open aorta repair received 
significantly more crystalloid transfusion than did sub-
jects undergoing infra-inguinal surgery (P = 0.03).
Aortic clamping significantly elevated levels of several 
cytokines, especially IL‑6 and HGF
The majority of the values for IFN-α2, LIF, IL-1α, IL-3, 
IL-12p40, IL-15, bFGF, RANTES and TNF-β were below 
the detection limit, and were left out of the statistical 
analysis.
 For aortic clamping there was a significant rise in the 
level of IL-6 (667 %, P = 0.016), IL-8 (75 %, P = 0.047), 
IL-2Rα (152  %, P  =  0.031), IL-16 (129  %, P  =  0.031), 
GROα (252  %, P  =  0.031), HGF (760  %, P  =  0.016), 
M-CSF (853  %, P  =  0.016), and SDF-1α (447  %, 
P  =  0.016) using matched pair values across time and 
the Wilcoxon signed rank test. For cross clamping of 
the common femoral artery there was only a significant 
Table 1 Description of baseline characteristics between patients undergoing clamping of the aorta vs. common femoral 
artery
Prevalence presented as percentage and numerical values as median and inter-quartile range (IQR). Difference between groups calculated using the * Chi square test 
and ** Mann–Whitney U test
Aorta (n = 6) Femoral (n = 6) P value
A (Baseline characteristics)
 Gender (F/M %) 50/50 % 33/67 % NS*
 Age (years) 64.5 (61–71) 72.5 (64–77) NS**
 Hypertension 67 % 67 % NS*
 Coronary artery disease 33 % 50 % NS*
 Dyslipidemia 17 % 17 % NS*
 COPD 33 % 33 % NS*
 Diabetes 17 % 17 % NS*
 Renal insufficiency 17 % 33 % NS*
 Systolic BP (mmHg) 160 (146–174) 148 (133–152) NS**
 Creatine (μmol/L) 78 (61–101) 92 (68–136) NS**
 CRP (mg/L) 8 (3–19) 8 (3–18) NS**
B (Procedure related variables)
 Procedure time (min) 213 (148–233) 150 (103–218) NS**
 Clamping time (min) 75 (45–98) 78 (38–135) NS**
 Blood loss (mL) 1025 (500–2890) 250 (88–1425) NS**
 Amount of saline transfusion between sampling 
(mL)
6250 (4575–8800) 2975 (2575–5100) 0.03**
 Time from clamping to second sample (h) 29 (22–38) 21 (20–28) NS**
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increase in the level of IL-6 (96 %, P = 0.031) and GROα 
(84  %, P  =  0.031). All of the cytokines, which under-
went a significant alteration due to clamping were then 
tested for the effect of aortic clamping versus femoral 
artery clamping between the groups. These results are 
presented in Table  2. First, the pre-operative baseline 
values between the groups were tested to ensure that 
the effect of clamping was not affected by any underly-
ing baseline differences. No significant differences in the 
cytokine levels between the groups could be seen in pre-
operative sampling. For aortic clamping the most pro-
noun change was observed in the elevation of IL-6, when 
compared to femoral clamping (667 vs. 96 %, respectively, 
P = 0.006). As was also seen for HGF (760 % increase for 
aortic clamping vs. 33  % increase for femoral clamping, 
P = 0.045). Figure 1 illustrates the differences of aortic vs. 
femoral clamping on IL-6 and HGF as matched pairs. All 
the corresponding raw values are presented in Additional 
file 1: Table S1. Other cytokines failed to show statistical 
increase in the aortic clamping when compared to the 
femoral clamping as matched pairs. 
CD39 and CD73 decrease significantly after clamping 
aortic clamping
Baseline values of CD39 and CD73 did not differ between 
groups (Table  3). After aortic clamping both CD39 and 
CD73 significantly declined from baseline levels, see 
Fig.  2 and Table  3. CD39 declined an average of 43  % 
(P  =  0.047), ranging from 2 to 63  % decline. A similar 
46 % decline was seen in CD73 (P = 0.016), ranging from 
21 to 55 % decline (Fig. 2). In cross clamping of the com-
mon femoral artery there was no significant decrease in 
CD39, but a significant decrease in CD73 activity (Fig. 2). 
CD39 decreased an average of 6  %, ranging from 13  % 
increase to 24 % decrease. After common femoral artery 
clamping CD73 had a more constant, yet significant aver-
age 25  % decrease, ranging from 16 to 30  % decrease, 
P =  0.016). Thus, a stronger decline was seen in aortic 
clamping than in clamping of the femoral artery in both 
CD39 (43 vs 6  % decrease, respectively, P =  0.037) and 
CD73 (46 vs. 25 % decrease, respectively, P = 0.11), but 
for CD39 this was more evident. Circulating ATP and 
ADP levels showed no consistent or significant changes 
between pre- and post-operative samples in either pro-
cedure. Both increases and decreases were seen between 
pre- and post-operative levels, which amounted to slight 
but non-significant decrease in both ATP and ADP 
(Table  3). All raw values of components of purinergic 
signaling are presented in Additional file 1: Table S1.
HIF‑1a increased after clamping unless the subject 
underwent blood transfusion
HIF-1α was mostly associated with an increase after 
clamping in both groups. However, significant blood 
loss and consequent blood transfusion was associated 
with an opposing effect. All subjects who received blood 
transfusion had a decrease in HIF-1α (average decrease 
34 %, range 0–87 % decrease). Subjects undergoing aortic 
clamping and not receiving blood transfusion had aver-
age 17 % increase in HIF-1α ranging from 15–61 %, and 
subject undergoing clamping of the femoral artery and 
not receiving blood transfusion had an average HIF-1α 
increase of 18 %, ranging from 11–36 %. Although there 
was a tendency of higher HIF-1α response after aortic 
clamping there was no significant difference between 
HIF-1α in the groups. The HIF-1α response between the 
pre- and post-operative values was however significantly 
affected depending on whether the blood transfusion was 
received or not (P = 0.007), see Fig. 3.
Discussion of results
This study clearly shows that open infra-renal aorta 
repair significantly elevates levels of several circulating 
cytokines and growth factors, but in particular IL-6 and 
HGF. Both markers have been associated with worse dis-
ease prognosis in SIRS, sepsis, ARDS and severe acute 
pancreatitis (Parsons et al. 2005; Nieminen et al. 2014).
The role of IL-6 as an acute phase pro-inflammatory 
mediator is unquestionable. However, the elevation of 
HGF relating to SIRS after open aorta repair is a novel 
Table 2 Baseline values of  significantly altered cytokines 
presented as  median and  inter-quartile range (IQR) 
and  average percentage of  the change after  cross clamp-
ing of the aorta vs. common femoral artery
* Mann–Whitney U test
Aorta Femoral P value*
IL-6
 Baseline (pg/mL) 15.3 (10.8–17.7) 12.5 (11.1–24.5) NS
 % change 667 % 96 % 0.006
IL-8 40.0 (33.2–51.3) 29.5 (27.0–39.1) NS
75 % 17 % 0.361
IL-2Rα 89.7 (77.4–160) 65 (39.6–174) NS
152 % 7 % 0.068
IL-16 142 (81–172) 154 (46–194) NS
129 % 20 % 0.068
GROα 30.9 (20.8–52.5) 58.0 (34.7–77.9) NS
252 % 84 % 0.144
HGF 681 (599–865) 688 (560–1225) NS
760 % 33 % 0.045
M-CSF 10.3 (5.45–15.9) 11.1 (4.33–57.5) NS
853 % 197 % 0.055
SDF-1α 69.6 (32.0–130) 75.4 (41.3–77) NS
447 % 10 % 0.154
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finding. The role of HGF is controversial according to the 
background literature. HGF is considered anti-inflamma-
tory by nature, and a necessary mediator of repair mech-
anisms (Shimizu et al. 2012). In several animal models it 
has been considered protective and even a possible tar-
get for drug development to prevent organ failure (Gong 
2008). HGF has been shown to down regulate inflamma-
tion and leukocyte extravasation by attenuating TNFα 
induced expression of intercellular adhesion molecule-1 
(ICAM-1), vascular adhesion molecule-1 (VCAM-1) 
(Mine et  al. 1998), and E-selectin (Gong et  al. 2006). 
However, this study indicates that the inflammatory 
response of open aorta repair is not TNFα mediated, as 
TNFα was not affected from cross clamping of the aorta. 
Thus, the HGF response in open aorta repair could be an 
acute repair mechanism in response to severe hypoxia. 
Despite of its known anti-inflammatory mechanisms, 
HGF has several pleiotropic actions, and has been shown 
to be a potent mediator of neutrophil adhesion via integ-
rin activation (Mine et al. 1998) and is highly expressed 
in polymorphonuclear leukocytes at acute sites of inflam-
mation (Matsushima et  al. 2004). Neutrophil infiltra-
tion highlights sites of acute inflammation, especially in 
response to ischemia and reperfusion. This may explain 
why HGF is highly elevated in severe acute conditions 
and may be a predictor of poor prognosis. According to 
the results of this study HGF had a strong positive cor-
relation with IL-6 (R = 0.52, P = 0.01, data not shown).
All this translates to the conclusion that it is namely the 
hypoxia induced systemic acute inflammatory response 


























 pg/mL pg/mL 
Fig. 1 Change in IL-6 and HGF levels (pg/mL) after cross clamping of the aorta (red) and common femoral artery (blue) presented as matched pairs 
of pre- and post-operative samples
Table 3 Baseline values of  ATP, ADP, CD39 and  CD73 presented as  median and  range, and  average percentage change 
(and range) after clamping
Significance of change after clamping calculated using matched pairs
* Wilcoxon sign rank test
Aorta baseline Average change P value* Femoral baseline Average change P value*
ATP (nmol/L) 3276 (1582–4476) −6 % (−30 to 50 %) NS 4336 (2731–5187) −21 % (−42 to 21 %) NS
ADP (nmol/L) 2790 (1243–3317) −9 % (−45 to 29 %) NS 1755 (1219–3944) −4 % (−56 to 71 %) NS
CD39 (nmol/mL/h) 20.5 (13–27) −43 % (−2 to −63 %) 0.047 15 (8–20) −6 % (−24 to 13 %) NS
CD73 (nmol/mL/h) 243 (184–251) −46 % (−21 to −55 %) 0.016 303 (224–549) −25 % (−16 to −30 %) 0.016
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that makes aortic clamping the strain it is. One could 
argue that the elevation in circulating cytokines seen 
here is a response to the overall surgical trauma patients 
undergo in open repair, which is extensive. Most likely 
surgical trauma does contribute to some of the elevation, 
e.g. in more slowly acting cytokines (IL-8 and IL-16) and 
growth factors (GROα and SDF-1α) as seen here, simi-
lar to the rise of CRP seen later on after a major surgery. 
However, here we have shown a dramatic acute pro-
inflammatory response in the elevation of IL-6 and HGF, 
which are known to be induced by hypoxia and central 
tissue resections, but not by surgical trauma per se (Yam-
ada et  al. 1998). The known excessive need for transfu-
sion of crystalloid fluids relating to open aorta repair, 
as seen in this study (Table 1), would more likely have a 
diluting rather than a lifting affect on cytokine levels.
The excessive need for fluid transfusion to maintain 
an optimum hemodynamic level relating to clamping 
and un-clamping of the aorta can in part be a result of 
impaired adenosine production as seen here in decreased 
CD39 and CD73 activity especially in subjects under-
going aortic clamping. To some extent CD39 activity 
even increased in subjects undergoing femoral clamping 
(Fig. 2). HIF-1α activated adenosine production by CD73 
is considered the key of maintaining vascular integrity 
and preventing vascular leak (Thompson et al. 2004; Hart 
et  al. 2011). For patients undergoing open aorta repair 
the essence of this mechanism is even more crucial due 
to the high volume of transfused fluids. But why do CD39 
and CD73 levels significantly decline in subjects under-



















Fig. 2 Change in CD73 and CD39 activity activities (nmol/mL/h) after cross clamping of the aorta (red) and common femoral artery (blue) pre-
sented as matched pairs of pre- and post-operative samples
Fig. 3 Percent change of HIF-1a levels in all patients after clamping 
depending on was whether a blood transfusion was received (n 4) or 
not (n 8). Difference between the presented groups P = 0.007 using 
the Mann–Whitney U test
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when they should go up? Hypoxia is a known key driver 
of CD39 and CD73 activity (Semenza 2010; Schwartz 
et  al. 2011). An adequate elevation is seen in HIF-1α, 
unless blood loss was significant and the subject under-
went blood transfusion (Fig. 3). It is a novel finding that 
blood transfusion impairs the HIF-1α response, but helps 
to explain why blood transfusion is significantly associ-
ated with worse outcome and ischemia related morbid-
ity (Murphy et  al. 2007; Marik and Corwin 2008; Patel 
et  al. 2014). This, however, is inadequate to explain an 
impaired CD39/CD73 response since this was seen in all 
subjects, even in subjects without blood transfusion and 
with an adequate elevation of HIF-1α. Perhaps CD39 and 
CD73 were consumed to compensate for elevated ATP 
and ADP levels (Yegutkin 2015) as ATP and ADP levels 
showed no consistent or significant alterations in either 
direction between the pre- and post-operative sam-
ples. Or perhaps, despite an increased expression at the 
endothelium, CD39 and CD73 do not shed into circula-
tion as anticipated. Thus, an increase is not yet seen in 
soluble values measured here at the first post-operative 
day. A similar late rise in soluble activity of CD73 is seen 
when its expression is induced with the administration of 
intra venous interferon beta in humans (Bellingan et  al. 
2014).
Limitations of the study
The current study has marked limitations. First, and 
most importantly, this study is highly limited by the low 
number of study subjects. Due to the low number of 
subjects it is virtually impossible to find statistical differ-
ences between the baseline characteristics of the study 
groups. Despite this dilemma, the differences between 
the observed inflammatory responses and repair mech-
anisms, on the other hand, are statistically strong and 
quite clear. Thus, we postulate that the observed molec-
ular changes would only become stronger with a big-
ger study population. Our objective was to capture true 
PAD patients undergoing aortic clamping and study the 
observed mechanisms. These patients were scarce. Dur-
ing the study period several open AAA procedures were 
performed. These patients were not included, because 
the baseline values of cytokines and purinergic signaling 
can be significantly altered due to PAD (Jalkanen et  al. 
2015). An additional limitation is that we only focused 
on two distinct time points: the morning prior to the 
operation and the morning of the first post-operative 
day. However, there is a clear rationale for this. IL-6 has 
been shown to be a key measure of SIRS and predict poor 
outcome in several conditions (Sakon et al. 1996; Matsu-
shima et al. 2004; Nieminen et al. 2014), including major 
surgery (Yamada et al. 1998; Namekata et al. 2000). IL-6 
levels peek at the first post-operative day, at around 24 h, 
while for example CRP rises later on after a major sur-
gery (Vasdekis et  al. 2008; Watt et  al. 2015). Similarly, 
organ failures commonly start to develop during the first 
post-operative day and become evident at the second, 
or even on the third post-operative day. Thus, we postu-
late that the first post-operative day is a watershed and 
as IL-6 peeks then, the repair mechanisms should also be 
in action at this time point. From the studies reporting 
increased CD73 expression in humans (Bellingan et  al. 
2014) we can also postulate that after HIF-1α activation 
CD73 expression should peek at the first post-operative 
day.
Conclusions
Open infra-renal aorta repair is associated with a sys-
temic inflammatory response, but in addition accord-
ing to the present study an impaired CD39 and CD73 
response to attenuate inflammation. This helps to explain 
severe morbidity and mortality related to open aorta 
repair. In conclusion, we wish to point out that despite 
a small study the witnessed phenomenon is obvious and 
merely proposes an explanatory molecular mechanism 
behind the burden of aortic clamping. Hypoxia induced 
inflammation and impaired hypoxia related repair mech-
anisms seen here relating to open aorta repair require 
further research and could serve as a target for opera-
tive preconditioning and better patient outcome. Such a 
therapy could be pre-operative statin loading, which is in 
common use for example in coronary artery bypass graft-
ing (CABG). Statins are known for their anti-inflamma-
tory properties and have been shown to have beneficial 
effects on CD39 and CD73 levels (Kaneider et  al. 2002; 
Jalkanen et al. 2015). Pre-operative statin therapy has also 
been associated with better outcome after major vascu-
lar surgery (Durazzo et al. 2004; Le Manach et al. 2011; 
Sanders et  al. 2013). However, we still lack a decisive 
multicenter randomized trial on the effect statin load-
ing on infra-renal aorta repair against SIRS and organ 
dysfunction. Another possible therapy could be pre-
operative administration of intravenous interferon beta. 
It is known to up-regulate CD73, attenuate inflammation 
and prevent vascular leakage especially in the lungs (Kiss 
et al. 2007), and has shown promising initial results in the 
treatment of ARDS in humans (Bellingan et al. 2014).
Methods
Study subjects
As a part of the PURE ASO Study (The Role of Purinergic 
Signaling in Atherosclerosis, approved by the local Ethi-
cal Committee of the Hospital District of Southwestern 
Finland) consecutive blood samples were gathered for 1 
year from non-urgent elective PAD patients admitted to 
the Department of Vascular Surgery of Turku University 
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Hospital, Finland (Jalkanen et al. 2015). The department 
is a primary vascular surgery referral center for a popula-
tion of 360,000 inhabitants. During enrollment 227 suit-
able patients were seen and 226 gave written informed 
consent. Out of these 226 PAD patients 6 went through 
open infra-renal abdominal aorta repair (1 for Leriche’s 
Syndrome, and 5 for TASC D aorta-iliac lesions accom-
panied with a repairable AAA). For these 6 subjects 
undergoing aortic clamping 6 age and risk factor matched 
subjects undergoing common femoral artery clamping 
during the same hospital stay as the aortic reconstruc-
tions were randomly picked as control subjects (5 of 
these subjects had femoral endarcterectomy done and 1 
subject underwent a femoropopliteal bypass to the proxi-
mal popliteal artery with a vascular prostheses). All 12 
study subjects had claudication as their manifestation 
of PAD. For these 12 study subjects both pre- and post-
operative blood samples were drawn. Otherwise, the 
PURE ASO Study population only went through the pre-
operative blood sampling.
Blood sampling and analyses
All samples were serum from centrifuged whole blood 
samples and plasma EDTA. The first samples were drawn 
in the morning of the operative day after over night fast-
ing. The second sample was drawn the following morn-
ing after the operation. At this point patients were still 
fasting. After centrifugation the serum samples were 
stored at −70 °C until analyses. All analyses were done at 
once with the same magnetic bead suspension array kit 
of Bio-Plex Pro Human Cytokine 21- and 27-plex panels 
(Bio-Rad, Hercules, CA, USA) according to the manu-
facturer’s instructions except that the amount of beads, 
detection antibodies and streptavidin–phycoeryth-
rin conjugate were used at half of their recommended 
concentration as described previously (Nieminen et  al. 
2014). The results were analyzed using the Bio-Plex 200 
System, and calculated using the Bio-Plex Manager 6.0 
software (Bio-Rad Laboratories, Hercules, CA, USA). 
The persons doing the cytokine analysis were unaware of 
patient procedures.
The 21-plex panel included interleukin 1α (IL-1α), IL-2 
receptor α (IL-2Rα), IL-3, IL-12p40, IL-16, IL-18, cuta-
neous T cell attracting chemokine (CTACK), growth-
regulated oncogene α (GROα), hepatocyte growth factor 
(HGF), interferon α2 (IFN-α2), leukemia inhibitory factor 
(LIF), monocyte chemotactic protein 3 (MCP-3), mac-
rophage colony-stimulating factor (M-CSF), macrophage 
migration inhibitory factor (MIG), monokine induced by 
IFN-γ (MIF), β-nerve growth factor (β-NGF), stem cell 
factor (SCF), stem cell growth factor β (SCGF-β), stromal 
cell–derived factor 1α (SDF-1α), tumor necrosis factor 
β (TNF-β) and TNF-related apoptosis inducing ligand 
(TRAIL). The 27-plex included IL-1β, IL-1 receptor 
antagonist, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, 
IL-12p70, IL- 13, IL-15, IL-17, basic fibroblast growth 
factor (bFGF), eotaxin, granulocyte colony-stimulating 
factor (G-CSF), granulocyte- macrophage colony-stim-
ulating factor (GM-CSF), IFN-γ, IFN-γ-induced protein 
10, monocyte chemotactic protein 1 (MCP-1), mac-
rophage inflammatory protein 1α (MIP-1α), MIP-1β, 
platelet-derived growth factor (PDGF), regulated on acti-
vation normal T cell expressed and secreted (RANTES), 
TNF-α and vascular endothelial growth factor (VEGF).
Measurement of soluble nucleotidase (CD39 and CD73) 
activities in human serum
For ADPase/NTPDase activity, serum (10 μL) was incu-
bated for 60 min at 37 °C in 80 μL of RPMI-1640 medium 
containing 5  mM β-glycerophosphate, 80 μM adenylate 
kinase inhibitor Ap5A, and 50 μM ADP with a [2,8-3H]
ADP tracer (Perkin Elmer, Boston, USA). Likewise, 
5′-nucleotidase activity was assayed by incubating 10 μL 
of serum for 60 min with 300 μM [2-3H]AMP (Quotient 
Bioresearch, GE Healthcare, Rushden, UK). Radiolabelled 
substrates and their dephosphorylated products were 
separated by thin-layer chromatography and quantified 
by scintillation β-counting. Enzymatic activities were 
expressed as nanomoles of 3H-substrate metabolized per 
hr by 1 mL of serum (Yegutkin 2015).
Quantification of ATP and ADP levels in human plasma
Briefly as described previously (Yegutkin et al. 2003), 10 
µL aliquots of EDTA plasma were transferred into two 
parallel wells of a white non-phosphorescent 96-well 
microplate containing 100 µL of PBS with (A) or without 
(B) a solution of 200 µM UTP and 5 U/mL NDP kinase 
from baker’s yeast S. cerevisiae (Sigma). Following the 
addition of 50 µL of ATP-monitoring reagent, sample 
luminescence was measured using a Tecan Infinite M200 
microplate reader (Salzburg, Austria). The difference in 
luminescence signals between well “A” (ATP + ADP) and 
“B” (only ATP) enabled the quantification of ADP con-
centration, which was converted into ATP through an 
NDP kinase-mediated reaction in the presence of exog-
enous UTP. This approach allows simultaneous meas-
urement of both ATP and ADP content within the same 
sample.
Measurement of HIF‑1a Activity in Human serum
HIF-1a activity of serum samples was analyzed using 
ELISA kit of Elabscience (Wuhan, China) according to 
the manufacturer’s instructions. The optical density (OD) 
values were read using Tecan Infinite M200 and Magel-
lan 7.2 software for Microsoft Windows (Tecan Group, 
Männedorf, Switzerland).
Page 8 of 9Jalkanen et al. SpringerPlus  (2016) 5:2 
Statistical analysis
Statistical analyses were performed using JMP 11.1 
Pro statistical software from SAS (SAS Institute Inc., 
Cary, NC, USA). Baseline characteristics of subjects are 
reported using medians and inter-quartile range (IQR). 
Comorbidities were gathered on a yes/no basis and are 
presented as a percentage of prevalence amongst sub-
jects. Difference between prevalence was compared using 
the Chi square test, and difference between numeric 
values between the groups using the Mann–Whitney 
U test. Cytokine results are given as median and IQR. 
Changes in cytokine levels after clamping are presented 
as percentage rise or fall from the baseline value. The sig-
nificance of the change of each cytokine level and compo-
nent of purinergic signaling in relation to clamping was 
measured using matched pair values across time and the 
Wilcoxon signed rank test. Cytokine levels that changed 
significantly because of clamping were then compared 
between the two study groups (aorta vs. common femo-
ral artery) using the Mann–Whitney U test.
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